Prenosis Inc. is an innovative artificial intelligence company focused on advancing precision medicine in acute care settings. The company has developed the Immunix™ precision medicine platform, which facilitates the creation of precision products and the real-time delivery of optimal therapies. Notably, Prenosis has achieved a significant milestone by validating the first FDA-authorized AI biomarker for sepsis, known as the Sepsis ImmunoScore™. With a commitment to improving patient care through cutting-edge technology, Prenosis is positioned at the forefront of healthcare innovation.